Company: INMB
Filing Date: 2025-06-30
Form Type: 424B5
Source: 0001213900-25-059298
Chunk: 37

Company: Inmune Bio, Inc.
Filing Date: 2025-06-30
Form: 424B5
Chunk 37
---
. You may also read and copy any document we file at the SEC’s Public Reference Room at 100 F Street,
NE, Washington, D.C. 20549. Please call the SEC at 1-800-SEC-0330 for further information on the Public Reference Room.

This prospectus is part of
a registration statement on Form S-3 that we filed with the SEC to register the securities offered hereby under the Securities Act of
1933, as amended. This prospectus does not contain all of the information included in the registration statement, including certain exhibits
and schedules. You may obtain the registration statement and exhibits to the registration statement from the SEC at the address listed
above or from the SEC’s internet site.

<div align='center'>13

INCORPORATION OF CERTAIN DOCUMENTS BY REFERENCE</div>

This prospectus is part of
a registration statement filed with the SEC. The SEC allows us to “incorporate by reference” into this prospectus the information
that we file with them, which means that we can disclose important information to you by referring you to those documents. The information
incorporated by reference is considered to be part of this prospectus, and information that we file later with the SEC will automatically
update and supersede this information. The following documents are incorporated by reference and made a part of this prospectus:

| ● | the description of our common stock contained in our Registration                                                                       
 Statement on Form 8-A filed with the                                                                                                    
 SEC on February 1, 2019 (File No. 001-38793), including any amendment or report filed for the purpose of updating such description; and |

| ● | all reports and other documents subsequently filed by us pursuant                                                                           
 to Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act after the date of this prospectus and prior to the termination of this offering. |

We also incorporate by reference
any future filings (other than information furnished under Item 2.02 or Item 7.01 of Form 8-K and exhibits furnished on such form that
are related to such items unless such Form 8-K expressly provides to the contrary) made with the SEC pursuant to Sections 13(a), 13(c),
14 or 15(d) of the Exchange Act, including those made after the date of the initial filing of the registration statement of which this
prospectus is a part and prior to effectiveness of such registration statement, until we